MUSTANG BIO, INC.
For the period ended Dec 31, 2024. Filed Mar 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 28, 2025
MBIO$0.39-0.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
INDEX TO FINANCIAL STATEMENTS
| Report of Independent Registered Public Accounting Firm (KPMG LLP, New York, NY; PCAOB ID: 185) | F-2 |
|---|---|
| Balance Sheets as of December 31, 2024 and 2023 | F-4 |
| Statements of Operations for the Years Ended December 31, 2024 and 2023 | F-5 |
| Statements of Changes in Stockholders’ Equity for the Years Ended December 31, 2024 and 2023 | F-6 |
| Statements of Cash Flows for the Years Ended December 31, 2024 and 2023 | F-7 |
| Notes to Financial Statements | F-8 – F-29 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.